CeO@NH functionalized electrodes for the rapid detection of SARS-CoV-2 spike receptor binding domain

A detection method based on an electrochemical aptasensor has been developed as an alternative fast, portable, simple, inexpensive, and high-accuracy detection method for detecting the SARS-CoV-2 Spike Receptor Binding Domain (spike RBD). The CeO 2 @NH 2 functionalized Screen Printed Carbon Electrod...

Full description

Saved in:
Bibliographic Details
Published inRSC advances Vol. 13; no. 9; pp. 5874 - 5884
Main Authors Triastuti, Ayu, Zakiyyah, Salma Nur, Gaffar, Shabarni, Anshori, Isa, Surawijaya, Akhmadi, Hidayat, Darmawan, Wiraswati, Hesti Lina, Yusuf, Muhammad, Hartati, Yeni Wahyuni
Format Journal Article
Published 16.02.2023
Online AccessGet full text

Cover

Loading…
More Information
Summary:A detection method based on an electrochemical aptasensor has been developed as an alternative fast, portable, simple, inexpensive, and high-accuracy detection method for detecting the SARS-CoV-2 Spike Receptor Binding Domain (spike RBD). The CeO 2 @NH 2 functionalized Screen Printed Carbon Electrode (SPCE) was used to immobilize an aminated aptamer of spike RBD protein via glutaraldehyde as a linker. The aptamer's interaction with the SARS-CoV-2 Spike RBD was measured via the [Fe(CN) 6 ] 4−/3− redox system signal. Experimental conditions were optimized using a Box-Behnken experimental design and showed that the optimal conditions of the SARS-CoV-2 aptasensor were 1.5 ng mL −1 of aptamer, immobilization of aptamer for 60 minutes, and Spike RBD incubation for 10 minutes. The developed aptasensor was able to detect the standard SARS-CoV-2 Spike RBD with a detection limit of 0.017 ng mL −1 in the range of 0.001-100 ng mL −1 . This aptasensor was used to detect salivary and oropharyngeal swab samples of normal individuals with the addition of Spike RBD, and the recoveries were 92.96% and 96.52%, respectively. The testing on nasopharyngeal swab samples of COVID-19 patients showed that the aptasensor results were comparable with the qRT-PCR results. Thus, the developed aptasensor has the potential to be applied as a SARS-CoV-2 rapid test method for clinical samples. A detection method based on an electrochemical aptasensor has been developed as an alternative fast, portable, simple, inexpensive, and high-accuracy detection method for detecting the SARS-CoV-2 Spike Receptor Binding Domain (spike RBD).
ISSN:2046-2069
DOI:10.1039/d2ra07560a